At the end of 2012, Ian Boulton was asked to present his views on the results of the Affordable Medicines Facility – malaria (AMFm) at the 11th Assises Panafricaines de Lutte Contre le Paludisme (11th Pan-African National Malaria Control Programmes Meeting), sponsored and organised Sanofi, under the title:-
Le devenir de l’AMFm: Bilan de la phase 1 et perspective – le modè le AMFm est – il viable sans les sources actuelles de financement?
(The Future of AMFm: The Results of Phase 1 and Future Prospects – is the model viable without the current funding?)